29 April 2020
“The plasma of a person who had been infected with a coronavirus was used as a test sample. This is the first such donor in Tatarstan Kazan University provides scientific support for this project to the Republican Blood Center. We are responsible for testing for the presence of antibodies in patients with COVID- 19,” said Director of the Center for Precision and Regenerative Medicine Albert Rizvanov.
ELISA testing takes about several hours and requires a specialized immunological laboratory. The test system has shown the ability to detect the presence of antibodies. Over the next week, the university plans to optimize the test further. The next step is to package and register the system.
“The next step is to create express tests based on test strips. We have purchased the necessary equipment, and we are expecting delivery from China to open a pilot production. During this time, we will finalize our test system, as well as the protein production system, and we will solve others biochemical and immunological tasks. The placement details are currently discussed with the DNA Research Center. The research team is working at KFU, so it would be more convenient to localize equipment here,” Rizvanov noted. “The equipment is versatile, and it can be used to produce various types of test systems. In the future, in the event of another pandemic, we will be technologically ready to deploy production systems for new challenges.”
Apart from the test strips, KFU is also working on a vaccine. First results should become available in late May.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024